Journal of Neurology

, Volume 259, Issue 6, pp 1181–1190 | Cite as

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

  • Nobuhiro Yuki
  • Norito Kokubun
  • Satoshi Kuwabara
  • Yukari Sekiguchi
  • Masafumi Ito
  • Masaaki Odaka
  • Koichi Hirata
  • Francesca Notturno
  • Antonino Uncini
Original Communication


Areflexia is part one of the clinical criteria required to make a diagnosis of Guillain–Barré syndrome (GBS). The diagnostic criteria were stringently developed to exclude non-GBS cases but there have been reports of patients with GBS following Campylobacter jejuni enteritis with normal and exaggerated deep tendon reflexes (DTRs). The aim of this study is to expand the existing diagnostic criteria to preserved DTRs. From the cohort of patients referred for anti-ganglioside antibody testing from hospitals throughout Japan, 48 GBS patients presented with preserved DTR at admission. Thirty-two patients had normal or exaggerated DTR throughout the course of illness whereas in 16 patients the DTR became absent or diminished during the course of the illness. IgG antibodies against GM1, GM1b, GD1a, or GalNAc-GD1a were frequently present in either group (84 vs. 94%), suggesting a close relationship between the two groups. We then investigated the clinical and laboratory findings of 213 GBS patients from three hospital cohorts. In 23 patients, eight presented with normal tendon reflexes throughout the clinical course of the illness. Twelve showed hyperreflexia, with at least one of the jerks experienced even at nadir, and exaggerated reflexes returning to normal at recovery. The other three had hyperreflexia throughout the disease course. Compared to 190 GBS patients with reduced or absent DTR, the 23 DTR-preserved patients more frequently presented with pure motor limb weakness (87 vs. 47%, p = 0.00026), could walk 5 m independently at the nadir (70 vs. 33%, p = 0.0012), more frequently had antibodies against GM1, GM1b, GD1a, or GalNAc-GD1a (74 vs. 47%, p = 0.014) and were more commonly diagnosed with acute motor axonal neuropathy (65 vs. 34%, p = 0.0075) than with acute inflammatory demyelinating polyneuropathy (13 vs. 43%, p = 0.0011). This study demonstrated that DTRs could be normal or hyperexcitable during the entire clinical course in approximately 10% of GBS patients. This possibility should be added in the diagnostic criteria for GBS to avoid delays in diagnosis and effective treatment to these patients.


Guillain–Barré syndrome Acute motor axonal neuropathy Acute inflammatory demyelinating polyneuropathy Anti-ganglioside antibody Campylobacter jejuni Tendon reflex 


  1. 1.
    Asbury AK (1981) Diagnostic considerations in Guillain–Barré syndrome. Ann Neurol 9(Suppl):1–5PubMedCrossRefGoogle Scholar
  2. 2.
    Asbury AK, Arnason BG, Karp HR, McFarlin DE (1978) Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol 3:565–566CrossRefGoogle Scholar
  3. 3.
    Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27(Suppl):S21–S24PubMedCrossRefGoogle Scholar
  4. 4.
    Asbury AK, Cornblath DR (1998) Preserved tendon reflexes in Campylobacter neuropathy: reply. Ann Neurol 43:547CrossRefGoogle Scholar
  5. 5.
    Brown WF, Snow R (1991) Patterns and severity of conduction abnormalities in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 54:768–774PubMedCrossRefGoogle Scholar
  6. 6.
    Capasso M, Caporale CM, Pomilio F, Gandolfi P, Lugaresi A, Uncini A (2003) Acute motor conduction block neuropathy: another Guillain–Barré syndrome variant. Neurology 61:617–622PubMedCrossRefGoogle Scholar
  7. 7.
    Capasso M, Notturno F, Mazoil C (2011) Involvement of sensory fibers in axonal subtypes of Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 82:664–670PubMedCrossRefGoogle Scholar
  8. 8.
    Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK (1996) Pathology of the motor-sensory axonal Guillain–Barré syndrome. Ann Neurol 39:17–28PubMedCrossRefGoogle Scholar
  9. 9.
    Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka KV, Swan AV (1998) Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol 44:780–788PubMedCrossRefGoogle Scholar
  10. 10.
    Hafer-Macko C, Hsieh S-T, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40:635–644PubMedCrossRefGoogle Scholar
  11. 11.
    Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39:625–635PubMedCrossRefGoogle Scholar
  12. 12.
    Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, Yuki N, Hattori T, Mori M (2005) Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome. Neurology 64:856–860PubMedCrossRefGoogle Scholar
  13. 13.
    Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain–Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597–605PubMedCrossRefGoogle Scholar
  14. 14.
    Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750–753PubMedCrossRefGoogle Scholar
  15. 15.
    Jackson CE, Barohn RJ, Mendell JR (1993) Acute paralytic syndrome in three American men: comparison with Chinese cases. Arch Neurol 50:732–735PubMedCrossRefGoogle Scholar
  16. 16.
    Jacobs BC, van Doorn PA, Schmitz PIM, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FGA (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Ann Neurol 40:181–187PubMedCrossRefGoogle Scholar
  17. 17.
    Kinsella LJ, Lange DJ, Trojaborg W, Sadiq SA, Younger DS, Latov N (1994) Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers. Neurology 44:1278–1282PubMedCrossRefGoogle Scholar
  18. 18.
    Koga M, Koike S, Hirata K, Yuki N (2005) Ambiguous value of Haemophilus influenzae isolation in Guillain–Barré and Fisher syndromes. J Neurol Neurosurg Psychiatry 76:1736–1738PubMedCrossRefGoogle Scholar
  19. 19.
    Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N (2010) Conduction block in acute motor axonal neuropathy. Brain 133:2897–2908PubMedCrossRefGoogle Scholar
  20. 20.
    Kuwabara S, Mori M, Ogawara K, Hattori T, Yuki N (2001) Indicators of rapid clinical recovery in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 70:560–562PubMedCrossRefGoogle Scholar
  21. 21.
    Kuwabara S, Nakata M, Sung JY, Mori M, Kato N, Hattori T, Koga M, Yuki N (2002) Hyperreflexia in axonal Guillain–Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci 199:89–92PubMedCrossRefGoogle Scholar
  22. 22.
    Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N (1999) Hyperreflexia in Guillain–Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry 67:180–184PubMedCrossRefGoogle Scholar
  23. 23.
    Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain–Barré syndrome. Ann Neurol 44:202–208PubMedCrossRefGoogle Scholar
  24. 24.
    Martens-Le Bouar H, Korinthenberg R (2002) Polyradiculoneuritis with myelitis: a rare differential diagnosis of Guillain–Barré syndrome. Neuropediatrics 33:93–96PubMedCrossRefGoogle Scholar
  25. 25.
    McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP, Liu TC, Gao CY, Mao JY, Blaser MJ, Mishu B, Asbury AK (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:333–342PubMedCrossRefGoogle Scholar
  26. 26.
    Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T (2003) Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 210:41–45PubMedCrossRefGoogle Scholar
  27. 27.
    Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624–631PubMedCrossRefGoogle Scholar
  28. 28.
    Olsson Y (1968) Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol (Berl) 10:26–33CrossRefGoogle Scholar
  29. 29.
    Oshima Y, Mitsui T, Endo I, Umaki Y, Matsumoto T (2001) Corticospinal tract involvement in a variant of Guillain–Barré syndrome. Eur Neurol 46:39–42PubMedCrossRefGoogle Scholar
  30. 30.
    Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24:73–78PubMedCrossRefGoogle Scholar
  31. 31.
    Podnar S, Vodusek DB (2000) Hyperreflexia in a patient with motor axonal Guillain–Barré syndrome. Eur J Neurol 7:727–730PubMedCrossRefGoogle Scholar
  32. 32.
    Rees JH, Soudain SE, Gregson NA, Hughes RAC (1995) Campylobacter jejuni infection and Guillain–Barré syndrome. N Engl J Med 333:1374–1379PubMedCrossRefGoogle Scholar
  33. 33.
    Schwerer B, Lassmann H, Kitz K, Bernheimer H (1986) Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol 72:55–61PubMedCrossRefGoogle Scholar
  34. 34.
    Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27:3956–3967PubMedCrossRefGoogle Scholar
  35. 35.
    Tagawa Y, Yuki N, Hirata K (2002) High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain–Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy. Eur Neurol 48:118–119PubMedCrossRefGoogle Scholar
  36. 36.
    Uncini A, Manzoli C, Notturno F, Capasso M (2010) Pitfalls in electrodiagnosis of Guillain–Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 81:1157–1163PubMedCrossRefGoogle Scholar
  37. 37.
    van der Meché FGA, Meulstee J, Vermeulen M, Kievit A (1988) Patterns of conduction failure in the Guillain–Barré syndrome. Brain 111:405–416PubMedCrossRefGoogle Scholar
  38. 38.
    Yuki N, Hirata K (1998) Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol 43:546–547PubMedCrossRefGoogle Scholar
  39. 39.
    Yuki N, Kuwabara S (2007) Axonal Guillain–Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst 12:238–249PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Nobuhiro Yuki
    • 1
  • Norito Kokubun
    • 2
  • Satoshi Kuwabara
    • 3
  • Yukari Sekiguchi
    • 3
  • Masafumi Ito
    • 2
  • Masaaki Odaka
    • 2
  • Koichi Hirata
    • 2
  • Francesca Notturno
    • 4
    • 5
  • Antonino Uncini
    • 4
    • 5
  1. 1.Departments of Microbiology and MedicineNational University of SingaporeSingaporeSingapore
  2. 2.Department of NeurologyDokkyo Medical UniversityTochigiJapan
  3. 3.Department of Neurology, Graduate School of MedicineChiba UniversityChibaJapan
  4. 4.Department of Neurosciences and ImagingUniversity “G. d’Annunzio”ChietiItaly
  5. 5.Neurocenter of Southern Switzerland (EOC)LuganoSwitzerland

Personalised recommendations